Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
19 June 2019
Closing Date:
23 July 2019
Location(s):
PL514 Miasto Wrocław (PL Poland/POLSKA)
Description:
Delivery of medicinal products resulting from the current needs of the Employer for a period of 12 months from the date of conclusion of the contract

1. The subject of the order is: "Supply of medicinal products resulting from the current needs of the Employer for a period of 12 months from the date of conclusion of the contract".

2. The Ordering Party has divided the object of the order into 80 parts / packages / tasks.

3. A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.

4. CPV code according to the Common Procurement Vocabulary: the main CPV code is: 33690000-3; various medicinal products.

5. Each Contractor may submit an offer for any number of parts.

6. The Contractor will be obliged to perform deliveries according to the current needs of the Employer based on the received demand defining the ordered assortment and the quantity of products.

7. The Contractor will deliver the ordered products at his own expense and risk.

8. Delivery period up to 24 hours for "cito" orders and up to 3 business days for current orders.


Package No. 1 - IMMUNOGLOBULIN

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 10. Recaparation for the prevention of oral infections in immunosuppressed patients

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 11 - Drugs used in infections

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package 12 - Antibiotics p / fungal

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 13 - ANTIBIOTICA

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


14 - Medicines used in infections

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 15 - ANTIBIOTICA

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package 16 - Virusostatica

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 17- ANTIBIOTICUM

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 18 - ANTIBIOTICUM

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 19 - ANTIBIOTICUM

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 2 - IMMUNOGLOBULIN

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 20 - ANTIBIOTICUM

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 21 - ANTIMYCOTICUM

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 22 - ANTIBIOTICA

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package 23 - Cytostatics - Pegylated asparginase

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package 24 - Cytostatics

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 25 - Obinutuzumab - (drug program - treatment of chronic lymphocytic leukemia obinutuzumab).

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package 26 - Cytostatics

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 27 - IMMUNOSTIMULANS, ANTIANAANIC

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 28 - IMMUNOMODULANS

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 29 - LEKI P / CANCER

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 3 - Subcutaneous immunoglobulin with recombinant hyaluronidase

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 30 - CYTOSTATICUM

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 31 - MONOCONOMIC ANTIBODY

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package 32 - Cytostatics

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 33 - CYTOSTATICUM

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 34 - IMMUNOSUPRESSIVUM

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 35 - CYTOSTATICUM, ANTILEUCAEMICUM

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package 36 - Immunosupressiva

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 37- CYTOSTATICA

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 38 - CYTOSTATICA

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 39 - IMMUNOSUPRESSIVUM

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 4 - IMMUNOGLOBULINUM

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package 40 - Cytostatics

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 41 - CYTOSTATICUM

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 42 - CYTOSTATICUM

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 43 - CYTOSTATICA

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 44 - CYTOSTATICUM, ANTIURETICUM

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 45 - ANTIBIOTICS

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package 46 - CALCIUM GLUCONATUM

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 47 - CYTOSTATICUM

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 48 - CYTOSTATICUM

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 49 - CYTOSTATICA

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 5 - IMMUNOGLOBULINS FOR SUBCONTROL

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package 50 - Cytostatics

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 51 - IMMUNOSTIMULANS, LEUCOPOIETICA

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 52 - Drug program (treatment of patients with immune thrombocytopenia)

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 53 - HORMONE

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 54 - Antagonist oestrogenorum

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 55 - ANTINEOPLASMATICA

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 56 - Protein kinase inhibitor

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 57 - ANTICOAGULANCE

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 58 - ANTILEUCAEMICUM, CYTOSTATICUM

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 59 - CYTOSTATICUM

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 6 - ALBUMINA

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 60 - ANTIDOTUM

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 61 - LEKI at AMPUŁKI

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 62 - HORMONA, ANTIANAEMICA

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 63 - IMMUNOSUPRESSIVA

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 64 - CYTOSTATICUM

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 65 - ANTINEOPLASMATICA

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 66 - VARIA

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 67 - IBRUTYNIB (drug program)

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package 68 - Various chemotherapeutics

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 69- PSYCHOTROPA, NARCOTICA

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 7 - ALBUMINA

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 70 - INFUNDIBILIA

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 71 - INFUNDIBILIA

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 72 - Oral preparations

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 73 - VARIA (Externum)

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 74 - HEPATOPROTECTIVUM

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Packet 75 - PROTON PUMP INHIBITORS

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package 76 - KORTYKOSTEROIDY

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 77 - Drug program: Treatment of primary and secondary myelofobrosis with Ruxolitinib

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package 78 - Drug program (treatment of CD30 resistant and recurrent lymphomas)

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 79 - IMMUNOGLOBULIN FOR PODSKÓRNA

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package 8 - Chemotherapy

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 80 - MONOCONOMIC ANTIBODY

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.


Package No. 9 - ANTIEMETICA

A detailed description of the subject of the order regarding the requirements for individual parts together with the number of forecast supplies subject to valuation is provided in Annex 2 - Assortment and price form.

Download full details as .pdf
The Buyer:
Dolnośląskie Centrum Transplantacji Komórkowych z Krajowym Bankiem Dawców Szpiku
CPV Code(s):
33600000 - Pharmaceutical products